CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.46M |
| 3 |
Gilead Sciences
GILD
|
$6.38M |
| 4 |
Amgen
AMGN
|
$6.24M |
| 5 |
Adobe
ADBE
|
$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.18M |
| 2 |
Analog Devices
ADI
|
$3.75M |
| 3 |
Amazon
AMZN
|
$3.48M |
| 4 |
lululemon athletica
LULU
|
$3.4M |
| 5 |
iQIYI
IQ
|
$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Hyatt Hotels
H
$13.8B
| $31.3K | 0.01% |
240
-3,100
| -93% | -$404K |
|
402
Atea Pharmaceuticals
AVIR
$267M
| $29.4K | 0.01% |
9,653
+7,514
| +351% | +$22.9K |
|
403
Vanda Pharmaceuticals
VNDA
$272M
| $28.1K | 0.01% |
6,658
+5,186
| +352% | +$21.9K |
|
404
Phibro Animal Health
PAHC
$1.6B
| $27.3K | 0.01% |
2,357
+1,843
| +359% | +$21.3K |
|
405
ATAI Life Sciences
ATAI
$980M
| $27.1K | 0.01% |
19,206
+14,948
| +351% | +$21.1K |
|
406
Ovid Therapeutics
OVID
$87.5M
| $26.3K | 0.01% |
+8,178
| New | +$26.3K |
|
407
Veralto
VLTO
$26.2B
| $23.9K | ﹤0.01% |
+290
| New | +$23.9K |
|
408
Charles River Laboratories
CRL
$8.07B
| $21K | ﹤0.01% |
89
| – | – |
|
409
Repligen
RGEN
$7.01B
| $20.7K | ﹤0.01% |
115
| – | – |
|
410
Edwards Lifesciences
EW
$47.5B
| $19.5K | ﹤0.01% |
256
| – | – |
|
411
IQVIA
IQV
$31.9B
| $19.4K | ﹤0.01% |
84
| – | – |
|
|
BLUE
412
DELISTED
bluebird bio
BLUE
| $17.5K | ﹤0.01% |
632
+495
| +361% | +$13.7K |
|
413
Ventyx Biosciences
VTYX
$180M
| $16.9K | ﹤0.01% |
6,832
+5,326
| +354% | +$13.2K |
|
414
Exact Sciences
EXAS
$10.2B
| $16K | ﹤0.01% |
216
| – | – |
|
415
Estee Lauder
EL
$32.1B
| $14.5K | ﹤0.01% |
99
-1,300
| -93% | -$190K |
|
416
Aclaris Therapeutics
ACRS
$227M
| $8.61K | ﹤0.01% |
8,196
+6,382
| +352% | +$6.7K |
|
|
OKUR
417
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $6.17K | ﹤0.01% |
+386
| New | +$6.17K |
|
418
Texas Roadhouse
TXRH
$11.2B
| $5.38K | ﹤0.01% |
44
| – | – |
|
419
Kroger
KR
$44.8B
| $2.74K | ﹤0.01% |
60
| – | – |
|
420
Ralph Lauren
RL
$18.9B
| $2.32K | ﹤0.01% |
16
| – | – |
|
|
NIU
421
Niu Technologies
NIU
$338M
| $2.19K | ﹤0.01% |
1,000
| – | – |
|
422
Hershey
HSY
$37.6B
| $1.86K | ﹤0.01% |
10
| – | – |
|
423
JD.com
JD
$44.6B
| $1.85K | ﹤0.01% |
64
-1,690
| -96% | -$48.8K |
|
424
Capri Holdings
CPRI
$2.53B
| $402 | ﹤0.01% |
8
| – | – |
|
|
FTCH
425
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $174 | ﹤0.01% |
7,800
| – | – |
|